相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
Drew Weissman et al.
CELL HOST & MICROBE (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
Alicia T. Widge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors
Sophie Uyoga et al.
SCIENCE (2021)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Rational Vaccine Design in the Time of COVID-19
Dennis R. Burton et al.
CELL HOST & MICROBE (2020)
Infection and Rapid Transmission of SARS-CoV-2 in Ferrets
Young-Il Kim et al.
CELL HOST & MICROBE (2020)
Vaccine confidence in the time of COVID-19
Emily A. Harrison et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)
The Equitable Distribution of COVID-19 Therapeutics and Vaccines
Thomas J. Bollyky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
COVID-19 needs a Manhattan Project
Seth Berkley
SCIENCE (2020)
U.S. ‘Warp Speed’ vaccine effort comes out of the shadows
Jon Cohen
SCIENCE (2020)
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Abishek Chandrashekar et al.
SCIENCE (2020)
Rapid COVID-19 vaccine development
Barney S. Graham
SCIENCE (2020)
A strategic approach to COVID-19 vaccine R&D
Lawrence Corey et al.
SCIENCE (2020)
The search for a COVID-19 animal model
Seema S. Lakdawala et al.
SCIENCE (2020)
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2
Jianzhong Shi et al.
SCIENCE (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
Barry Rockx et al.
SCIENCE (2020)
The immune response to influenza in older humans: beyond immune senescence
Janet E. McElhaney et al.
IMMUNITY & AGEING (2020)
Presymptomatic Transmission of SARS-CoV-2-Singapore, January 23-March 16, 2020
Wycliffe E. Wei et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
Sin Fun Sia et al.
NATURE (2020)
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
Linlin Bao et al.
NATURE (2020)
Covid-19 and Immunity in Aging Populations - A New Research Agenda
Wayne C. Koff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials
Shengli Xia et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens
Jayanthi Wolf et al.
NPJ VACCINES (2020)
The Case for Why Africa Should Host COVID-19 Candidate Vaccine Trials
Jerome Amir Singh
JOURNAL OF INFECTIOUS DISEASES (2020)
Multivalue ethical framework for fair global allocation of a COVID-19 vaccine
Yangzi Liu et al.
JOURNAL OF MEDICAL ETHICS (2020)
COVID-19 is an emergent disease of aging
Didac Santesmasses et al.
AGING CELL (2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli et al.
CELL (2020)
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Julian Braun et al.
NATURE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
Ching-Lin Hsieh et al.
SCIENCE (2020)
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques
Wei Deng et al.
SCIENCE (2020)
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer et al.
SCIENCE (2020)
Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?
John S. Tsang et al.
TRENDS IN IMMUNOLOGY (2020)
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Denis Y. Logunov et al.
LANCET (2020)
COVID-19 vaccines: how to ensure Africa has access
John N. Nkengasong et al.
NATURE (2020)
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
Kenneth H. Dinnon et al.
NATURE (2020)
Animal models for COVID-19
Cesar Munoz-Fontela et al.
NATURE (2020)
Evolution of the COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
E. J. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
COVID-19 in Africa: Dampening the storm?
Moustapha Mbow et al.
SCIENCE (2020)
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Prabhu S. Arunachalam et al.
SCIENCE (2020)
VIEWPOINT: COVID-19 Understanding COVID-19 vaccine efficacy
Marc Lipsitch et al.
SCIENCE (2020)
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
Sandhya Bangaru et al.
SCIENCE (2020)
Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
Ellen Shrock et al.
SCIENCE (2020)
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Qian Zhang et al.
SCIENCE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
Prospects for a safe COVID-19 vaccine
Barton F. Haynes et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
Angkana T. Huang et al.
NATURE COMMUNICATIONS (2020)
Covid-19 vaccine trial protocols released
Peter Doshi
BMJ-BRITISH MEDICAL JOURNAL (2020)
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Maheshi N. Ramasamy et al.
LANCET (2020)
Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics: Applying Lessons from Past Outbreaks
John Billington et al.
HEALTH SECURITY (2020)
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
Kevin W. Ng et al.
SCIENCE (2020)
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Ania Wajnberg et al.
SCIENCE (2020)
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population
Annalisa Ciabattini et al.
SEMINARS IN IMMUNOPATHOLOGY (2020)
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum et al.
ELIFE (2020)
Age-related rhesus macaque models of COVID-19
Pin Yu et al.
ANIMAL MODELS AND EXPERIMENTAL MEDICINE (2020)
Vaccines and global health: In search of a sustainable model for vaccine development and delivery
Rino Rappuoli et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships
Joseph S. Bresee et al.
VACCINE (2019)
Aging and the Immune System: the Impact of Immunosenescence on Viral Infection, Immunity and Vaccine Immunogenicity
Soo-Jin Oh et al.
IMMUNE NETWORK (2019)
Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis
Jason K. H. Lee et al.
EXPERT REVIEW OF VACCINES (2018)
Causes of impaired oral vaccine efficacy in developing countries
Edward P. K. Parker et al.
FUTURE MICROBIOLOGY (2018)
TORC1 inhibition enhances immune function and reduces infections in the elderly
Joan B. Mannick et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Vaccines for the elderly: current use and future challenges
Birgit Weinberger
IMMUNITY & AGEING (2018)
Chronic schistosomiasis suppresses HIV-specific responses to DNA-MVA and MVA-gp140 Env vaccine regimens despite antihelminthic treatment and increases helminth-associated pathology in a mouse model
Godfrey A. Dzhivhuho et al.
PLOS PATHOGENS (2018)
The complexity and cost of vaccine manufacturing - An overview
Stanley Plotkin et al.
VACCINE (2017)
Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge
Sinthujan Jegaskanda et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
A. L. Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Immunosenescence: Implications for response to infection and vaccination in older people
Alejandra Pera et al.
MATURITAS (2015)
Biological challenges to effective vaccines in the developing world
Nicholas C. Grassly et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2015)
Beyond adjuvants: Antagonizing inflammation to enhance vaccine immunity
Galit Alter et al.
VACCINE (2015)
Animal models for SARS and MERS coronaviruses
Lisa M. Gretebeck et al.
CURRENT OPINION IN VIROLOGY (2015)
Immune activation alters cellular and humoral responses to yellow fever 17D vaccine
Enoch Muyanja et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
Carlos A. DiazGranados et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Protein carriers of conjugate vaccines Characteristics, development, and clinical trials
Michael E. Pichichero
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Optimal Vaccine Allocation for the Early Mitigation of Pandemic Influenza
Laura Matrajt et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Molecular Determinants of Severe Acute Respiratory Syndrome Coronavirus Pathogenesis and Virulence in Young and Aged Mouse Models of Human Disease
Matthew Frieman et al.
JOURNAL OF VIROLOGY (2012)
Differential Pathological and Immune Responses in Newly Weaned Ferrets Are Associated with a Mild Clinical Outcome of Pandemic 2009 H1N1 Infection
Stephen S. H. Huang et al.
JOURNAL OF VIROLOGY (2012)
MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
Surender Khurana et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Negotiating Equitable Access to Influenza Vaccines: Global Health Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1
David P. Fidler
PLOS MEDICINE (2010)
Poverty, Wealth, and Access to Pandemic Influenza Vaccines.
Tadataka Yamada
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Biology of immune responses to vaccines in elderly persons
Birgit Weinberger et al.
CLINICAL INFECTIOUS DISEASES (2008)
An immunosuppressed Syrian golden hamster model for SARS-CoV infection
Scott R. Schaecher et al.
VIROLOGY (2008)
Inhibition of severe acute respiratory syndrome-associated coronavirus infection by equine neutralizing antibody in golden Syrian hamsters
Guangyu Zhao et al.
VIRAL IMMUNOLOGY (2007)
Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus
Paul B. McCray et al.
JOURNAL OF VIROLOGY (2007)
Cynomolgus macaque as an animal model for severe acute respiratory syndrome
James V. Lawler et al.
PLOS MEDICINE (2006)
Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters
A Roberts et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Antibody response to influenza vaccination in the elderly: A quantitative review
K Goodwin et al.
VACCINE (2006)
Severe acute respiratory syndrome coronavirus infection of Golden Syrian hamsters
A Roberts et al.
JOURNAL OF VIROLOGY (2005)
The Japanese experience with vaccinating schoolchildren against influenza.
TA Reichert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
